Long COVID is likely to cost the U.S. economy trillions of dollars and will almost certainly affect multiple industries, experts are predicting.
and it is too early to know if repeat infections increase long COVID risks. There is also no definitive data on how fast or how many people are recovering. Economists often assume that those with long COVID will recover at some point, Bach noted, but she is careful not to make assumptions.
“If people are impaired longer than we think and if the impairment turns out to be severe, then we can have a lot of people who need services like disability insurance,” Cutler says.Policies that support the research and clinical work necessary to prevent and treat long COVID are essential, experts say.Employers also have a role, and experts say there are a number of accommodations businesses should consider.
Some long COVID patients told Bach they simply assumed they would not get SSDI and did not even bother applying. She stressed that working Americans with debilitating long COVID should be aware that their condition is. But the challenge, based on guidance issued by the government, is that not all cases of long COVID qualify as a disability and that individual assessments are necessary.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Long COVID risk falls only slightly after vaccination, huge study showsVaccination against SARS-CoV-2 lowers the risk of long COVID after infection by only about 15%, according to a study of more than 13 million people
Read more »
What We Know About Long COVID So FarWhile the governments of the U.S. and several other countries formally recognize the existence of long COVID, the National Institutes of Health has yet to formally define it. There’s no approved treatment and the causes are not understood.
Read more »
What We Know About Long COVID So FarHere's what is known: LongCOVID is a post-viral condition affecting people who become infected with SARS-CoV-2. It can be utterly debilitating or mildly annoying. It's affecting enough people to cause concern for employers, health insurers + governments.
Read more »
Mounting evidence shows autoimmune responses play a significant role in long CovidRecent research suggests people with long Covid are more likely to have markers of autoimmune disease in their blood a year after infection.
Read more »
How Long Does COVID Immunity Last With The New Bivalent Booster?There's a new COVID-19 shot that targets omicron and its subvariants. But does your protection fade after a certain amount of time?
Read more »